Category Specific RSS

News

Green with envy: RotoGro rolls up purchase order for medicinal cannabis facility

Touted as a miracle cure for just about any ailment, medicinal cannabis has been an interesting point of contention in healthcare for years now. The media hype around the stuff has increased, patient demand has increased, and global production is booming (legally).

Canadian based Wolf Island Cannabis is currently constructing a cannabis cultivation facility in Ontario, Canada to provide cannabis on a commercial-scale. The lawful, regulated facility will be state-of-the-art, designed to achieve high yields of a quality product.

To help achieve this, Wolf Island has reached out to RotoGro (ASX:RGI) to install their proprietary Rotational Garden Systems and Plant Nutrient Management System.

The technology purchase order for RotoGro’s products is worth CAD $380,000 (approx A$330k) with a 50% deposit to be paid to RotoGro by 9 July 2021. Systems will be delivered in late 2021. RotoGro’s service includes onsite assembly, installation, testing, certification, commissioning, training and IP support.

CEO of Rotogro, Michael Di Tommaso said: “Securing a binding purchase order from Wolf Island Cannabis for the Rotogro Model 420ITs and the Rotogro Fertigation System is an important step forward for the Company. The Wolf Island Cannabis Facility will be the first commercial-scale lawful cannabis cultivation facility in Ontario, Canada which utilises RotoGro’s patented and proprietary technology, enhancing RotoGro’s position in the Canadaian lawful cannabis cultivation space.”

“We will continue to make every effort to secure similar purchase orders, with several promising technology inquiries and venture proposals on the horizon. We will continue to press forward, providing the vertical farming industry with innovative and sustainable alternative technologies, and driving shareholder value. We are excited about the future of RotoGro, considering recent industry trends and the growth of indoor vertical farming.”

Both companies are keen to stake their claim as leaders in an increasingly competitive space with a huge global market currently at USD $16.5 billion and expected to rise at a compound annual growth rate of 22% to reach USD $46.2 billion by 2026.

Samantha Freidin

Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago